Viking Therapeutics to Report Q1 Earnings: What's in the Cards? [Yahoo! Finance]
Viking Therapeutics, Inc. (VKTX)
Last viking therapeutics, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.vikingtherapeutics.com
Company Research
Source: Yahoo! Finance
In the last reported quarter, the company's earnings missed expectations by about 19%. Since the company lacks a marketed drug in its portfolio, we do not expect it to record revenues. The Zacks Consensus Estimate for earnings is pegged at a loss of 34 cents per share. (Find the latest EPS estimates and surprises on Zacks Earnings Calendar) With no approved/marketed product in its portfolio, the focus of the first-quarter investor call will be on updates related to Viking's pipeline, which includes three candidates — VK2735 (for obesity), VK2809 (for non-alcoholic steatohepatitis [NASH]) and VK0214 (for X-linked adrenoleukodystrophy [X-ALD]). Last month, Viking announced that it has completed enrolment in the phase II VENTURE-Oral Dosing study evaluating the oral version of VK2735 over a 13-week treatment period. In our opinion, this announcement marks a milestone for the company since the study's initiation was declared in January. The quick recruitment indicates high patient a
Show less
Read more
Impact Snapshot
Event Time:
VKTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VKTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VKTX alerts
High impacting Viking Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
VKTX
News
- Why Viking Therapeutics Stock Bumped 3% Higher Today [Yahoo! Finance]Yahoo! Finance
- 3 Monster Stocks in the Making [Yahoo! Finance]Yahoo! Finance
- Why Viking Therapeutics Stock Was Victorious This Week [Yahoo! Finance]Yahoo! Finance
- Viking Therapeutics (NasdaqCM:VKTX) Reports Increased Net Loss of US$46 Million in Q1 2025 [Yahoo! Finance]Yahoo! Finance
- Where Will Viking Therapeutics Be in 3 Years? [Yahoo! Finance]Yahoo! Finance
VKTX
Earnings
- 4/23/25 - Miss
VKTX
Sec Filings
- 5/12/25 - Form SCHEDULE
- 4/24/25 - Form 10-Q
- 4/23/25 - Form DEFA14A
- VKTX's page on the SEC website